TrialLancet (London, England)2020

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.

Michael S Hofman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.